| Website | pro-cure.uk.com |
| Category | BioTech |
| Phone | 44-(0)1904-435125 |
| info@pro-cure.uk.com | |
| Employees |
| TOTAL | $2.24M |
| FUNDING TOTAL | $2.24M |
| Venture Round, 11/07 White Rose Technology Seedcorn Fund Yorkshire Cancer Research | £550k |
| Venture Round, 4/10 YFM Venture Finance Yorkshire Cancer Research Maven Capital Partners | $1.08M |
Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.
